The Health Outcomes Research Team conducts research that will enable government, industry, managed care, and academia to improve the effectiveness of health care and the management of health care systems, health care policy and the effective use of medication.
We assess health care delivery from an economic, clinical and humanistic view and disseminate this research widely. We are a highly energetic group of faculty and graduate students committed to high-quality research in pharmacy operations, health outcomes, quality, pharmaceutical economics, healthcare and drug policy, pharmacoeconomics, pharmacoepidemiology, pharmacovigilance and drugs of abuse.
We are an interdisciplinary group with backgrounds in pharmacy, medicine, industrial engineering, economics, finance, and quantitative analysis. We have studied drugs for cancer, end-stage renal disease, HIV/AIDS, hypertension and heart failure, hypercholesterolemia, asthma, diabetes, migraines, and ulcers, among other diseases.
Our research track encourages collaboration with faculty and students across the Academic Health Center. Additionally, the Carl H. Lindner College of Business offers graduate training in operations and business analytics, finance, economics, marketing, accounting, management, and information systems.
Faculty in this focus area include:
- Jill Boone, PharmD: Pain Management, Practice Based Quality improvement, Telementoring
- Jeff Guo, PhD: Pharmacoepidemiology, Pharmacoeconomics & Health Outcomes
- Pam Heaton, PhD: Pharmacoeconomics, Healthcare Policy, Ethics
- Ana Hincapie PhD, MS: Quality & Safety, Health Information Technology
- Alex Lin, PhD: Pharmacy Operations
- Neil MacKinnon, PhD: Medication safety